Key financial metrics and fundamentals for Sab Biotherapeutics, Inc. (SABS).
Market Cap
$35.3M
P/E Ratio
5.37
Forward P/E
--
EPS
$0.69
Forward EPS
Dividend Yield
Beta
Revenue
52-Week Low
52-Week High